Scarica l'app Stockscreener
7.72
4.22%
-0.34
Dopo l'orario di chiusura:
7.71
-0.010
-0.13%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché IBRX Giù?
Forum
Previsione
Immunitybio Inc Borsa (IBRX) Ultime notizie
Bronstein, Gewirtz & Grossman, LLC Is Investigating ImmunityBio, Inc. (IBRX) And Encourages Investors to Connect - ACCESS Newswire
ImmunityBio Confirms Trial Strength For Anktiva In Bladder Cancer - Stocktwits
U.S. Presidential Envoy Joins Albania’s Religious Leaders to Honor Mother Teresa as Bektashi Order Announces Signed American Cancer-Care Partnership - Albanian Daily News
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against ImmunityBio, Inc. (IBRX) and Encourages Investors to Learn More About the Investigation - ACCESS Newswire
ImmunityBio, Inc. Tokenized Stock (Robinhood) to British Pound Sterling Price Today | Live IBRX to GBP Converter & Exchange Rate - CryptoRank
ImmunityBio, Inc. Tokenized Stock (Robinhood) to Indonesian Rupiah Price Today | Live IBRX to IDR Converter & Exchange Rate - CryptoRank
ImmunityBio, Inc. Tokenized Stock (Robinhood) to South Korean Won Price Today | Live IBRX to KRW Converter & Exchange Rate - CryptoRank
ImmunityBio, Inc. Tokenized Stock (Robinhood) to Canadian Dollar Price Today | Live IBRX to CAD Converter & Exchange Rate - CryptoRank
ImmunityBio, Inc. Tokenized Stock (Robinhood) to United States Dollar Price Today | Live IBRX to USD Converter & Exchange Rate - CryptoRank
ImmunityBio, Inc. Tokenized Stock (Robinhood) to Euro Price Today | Live IBRX to EUR Converter & Exchange Rate - CryptoRank
ImmunityBio, Inc. Tokenized Stock (Robinhood) to Vietnamese Dong Price Today | Live IBRX to VND Converter & Exchange Rate - CryptoRank
IBRX Stock Climbs Overnight: ImmunityBio Declares ‘All Systems Go’ For Dunkirk Anktiva Manufacturing Push - Stocktwits
ImmunityBio Founder Pushes Back After FDA Warning Letter Over Anktiva Claims — Says Ad 'Never Aired At All' - Stocktwits
2026-09-06 | Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against ImmunityBio, Inc. (IBRX) and Encourages Investors to Learn More About the Investigation | NDAQ:IBRX | Press Release - Stockhouse
IBRX Stock Slips Overnight: Insider Sale Tests Retail Optimism Ahead Of FDA Growth Catalyst - Stocktwits
IBRX Stock Jumps Overnight: UAE Grants Anktiva Broadest Approval Yet After Founder’s ‘July Birthday News’ Tease - Stocktwits
IBRX Stock Slips Overnight: Founder Teases Turkey Push, Says AI Cancer Cell Robot Is ‘Almost There’ - Stocktwits
IBRX|Immunitybio Inc|Price:8.080|Chg%:-0.110 - TradingKey
Historical Data for ImmunityBio, Inc. Tokenized Stock (Robinhood) in USD - CryptoRank
ImmunityBio, Inc. Tokenized Stock (Robinhood) Exchanges IBRX Markets | Buy & Sell & Trade - CryptoRank
Why Is ImmunityBio (IBRX) Up 9.7% Since Last Earnings Report? - Yahoo Finance
ImmunityBio: None Of The Moonshots Is Priced In (NASDAQ:IBRX) - Seeking Alpha
ImmunityBio, Inc. (IBRX) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation - ACCESS Newswire
IBRX to IDR: ImmunityBio, Inc. • Robinhood Token Price in Indonesian Rupiah - CoinGecko
Bronstein, Gewirtz & Grossman, LLC Is Investigating ImmunityBio, Inc. (IBRX) And Encourages Stockholders to Connect - ACCESS Newswire
IBRX INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announc - The National Law Review
ImmunityBio, Inc. (IBRX) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Stockholders to Contact the Firm to Learn More About the Investigation - ACCESS Newswire
ImmunityBio, Inc. Tokenized Stock (Robinhood) Closing Price (USD)Quarterly - CryptoRank
ImmunityBio Stock Short Interest Falls to 31.8% - Quiver Quantitative
ImmunityBio: ANKTIVA Is Real, The Valuation Isn't (NASDAQ:IBRX) - Seeking Alpha
ImmunityBio Secures Five U.S. Patents for Anktiva in Bladder Cancer - Eastern Progress
ImmunityBio, Inc. (IBRX) Investors with Substantial Losses Have Opportunity to Lead Class Action LawsuitContact Kessler Topaz Meltzer & Check, LLP - Morningstar
IBRX Stock Eyes Best Week Since February: Founder Highlights New Anktiva-NK Cell Therapy Study - Stocktwits
IBRX Stock In Spotlight As FDA Scrutiny Prompts ImmunityBio To Withdraw Content, Tighten Oversight - Stocktwits
ImmunityBio (NASDAQ:IBRX): What Could Shape Its Next Move? - Kalkine Media
ImmunityBio, Inc. (NASDAQ:IBRX) Receives Consensus Recommendation of "Moderate Buy" from Analysts - MarketBeat
Patrick Soon-Shiong to Thomas Ichim: Thanks for Sharing Important Difference Between Il-2 and Il-15 - Oncodaily
IBRX Investors Have Opportunity to Lead ImmunityBio, Inc. Class A - The National Law Review
ImmunityBio (IBRX) Shares Moved, What Is Behind The Fresh Attention? - Sahm
147,000 Shares in ImmunityBio, Inc. $IBRX Purchased by Hussman Strategic Advisors Inc. - MarketBeat
Does Adding Jim Yong Kim to Leadership Shift ImmunityBio’s Global Strategy Narrative (IBRX)? - simplywall.st
IBRX Founder Soon-Shiong Bets On Anktiva's Next Growth Phase — ImmunityBio Posts Record Q2 Sales - Stocktwits
IBRX Stock In Spotlight: ImmunityBio To Unveil Fresh Anktiva And BCG Data Next Week - Stocktwits
IBRX Stock Price Prediction 2025-2026 | Immunitybio Inc Forecast - 24/7 Wall St.
ImmunityBio, Inc. (IBRX) options chain - Yahoo Finance UK
ImmunityBio, Inc. (IBRX) Investor Outlook: Exploring A 70% Upside Potential - DirectorsTalk Interviews
Jim Yong Kim Joins ImmunityBio as Vice Chairman - Oncodaily
ImmunityBio, Inc. • Robinhood Token (IBRX) Price Prediction for 2026 to 2031 - bybit.com
Archer Aviation (NYSE: ACHR) Among IBRX, JOBY, SCKT Leading Technology Stocks – Plus More in Focus - FinancialContent
ImmunityBio (IBRX) Tests Its Valuation After UAE ANKTIVA Approval Expands Its Reach - Sahm
ImmunityBio Names Former World Bank President Jim Yong Kim Vice Chairman - citybiz
ImmunityBio appoints Jim Yong Kim as vice chairman - Investing.com
ImmunityBio Appoints Dr. Jim Yong Kim, Former World Bank President and Global Health Leader, as Vice Chairman - ImmunityBio
3.04%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):